News and Events
Combining bevacizumab with erlotinib shrinks tumors in patients with rare and aggressive kidney cancer
Seventy-two percent of patients with HLRCC-associated kidney cancers, for which there previously was no known drug treatment, responded to the therapy in a clinical trial.
Read More
Clinical trial researching immunotherapy for tumors with specific genetic deficiencies
Mary Frances Wedekind Malone, D.O., Assistant Research Physician in the Pediatric Oncology Branch, is researching immunotherapy for SMARCB1- and SMARCA4-deficient tumors.
Read More
Clinical trial researching therapy for recurrent respiratory papillomatosis
Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is leading a trial researching drug therapy for recurrent respiratory papillomatosis.
Read More
Clinical trial researching T-cell therapy for epithelial cancers
Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is leading a trial researching T-cell therapy for gastric, breast, cervical, lung and other types of epithelial cancers.
Read More
Targeting sugar-molecule tags to proteins in the treatment of aggressive lymphomas
CCR researchers, led by Louis M. Staudt, M.D., Ph.D., have discovered a novel approach to treating diffuse large B-cell lymphoma with potentially fewer treatment-related side effects. Their work identifies and exploits the role of sugar-molecule modifications in B-cell survival.
Read More
Clinical trial researches therapy for pancreatic acinar cell carcinoma (PACC)
A clinical trial led by Christine Campo Alewine, M.D. Ph.D., Lasker Clinical Research Scholar in the Laboratory of Molecular Biology, is researching a therapy for pancreatic acinar cell carcinoma (PACC), a rare type of pancreatic tumor.
Read More
Clinical trial researching therapy for aggressive blood cancers
A clinical trial led by Christopher J. Melani, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is researching a combination drug therapy for aggressive blood cancers, such as non-Hodgkin lymphomas.
Read More
Clinical trial researches therapy for metastatic melanoma or renal cell carcinoma
A clinical trial led by Stephanie L. Goff, M.D., Associate Research Physician in the Surgery Branch, is researching a therapy for people with metastatic melanoma or renal cell carcinoma.
Read More
Clinical trial researches drug therapy for chronic graft-versus-host disease
A clinical trial led by Noa G. Holtzman, M.D., Assistant Research Physician in the Immune Deficiency Cellular Therapy Program, is researching a drug therapy for chronic graft-versus-host disease.
Read More
Clinical trial researches drug therapy for CNS tumors
A clinical trial led by Jing Wu, M.D., Ph.D., Lasker Clinical Research Scholar in the Neuro-Oncology Branch, is researching a drug therapy for aggressive diffuse gliomas.
Read More
2023 Frontiers in Basic Immunology
Dates: September 27-28, 2023
Location: Building 35, Room 610/620/630/640
The Center for Cancer Research at the National Cancer Institute is hosting a two-day national symposium on September 27-28, 2023 entitled 2023 Frontiers in Basic Immunology. The program includes recent advances in the field and should be an exciting forum for discussion and debate on the current understanding of basic immunological mechanisms. Check the website for a list of speakers.
Read More